Results 151 to 160 of about 1,549,285 (265)

Enhancing the quality and trustworthiness of large language model-generated summaries of clinical oncology literature. [PDF]

JAMIA Open
Stenzl A, Rogers E, Ananiadou S, Wang Y, Armstrong AJ, Sboner A, Cacciamani G, Schijvenaars BJA, Ahmed KR, Thomsen H, Wiemken T, Campello A, Sternberg CN.   +12 more
europepmc   +1 more source

Interpreting the effects of DNA polymerase variants at the structural level

Molecular Oncology, EarlyView.
Using MAVISp and molecular dynamics simulations, we analyzed over 60 000 missense variants in POLE and POLD1 from ClinVar, COSMIC, cBioPortal, and saturation mutagenesis. Identified mechanistic indicators, including stability, binding, and long‐range, enable structural interpretation, providing ACMG‐like evidence for possible reclassification of VUS ...
Matteo Arnaudi, Karolina Krzesińska, Ludovica Beltrame, Pablo Sánchez‐Izquierdo Besora, Matteo Tiberti, Mef Nilbert, Anna Rohlin, Elena Papaleo   +7 more
wiley   +1 more source

Relevant Irrelevancies

Perception, 2013
openaire   +3 more sources

Usability, Relevance, and User Engagement of a Government-Sponsored and Community Co-Designed Digital Mental Health Website During the COVID-19 Pandemic: A Pilot Study on Latino/a/x Adults. [PDF]

JMIR Form Res
Wright B, Zhang L, Meza JI, Rodriguez L, Contreras I, Terán V, Young AS, Nuño M, Dzou T, Aguilar-Gaxiola S, Wells KB.   +10 more
europepmc   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

Expert Evaluation of the Perceived Accuracy, Relevance, and Safety of Large Language Model-Generated Patient Information in Geriatrics: Cross-Condition Study. [PDF]

JMIR AI
Martini S, Schluessel S, Aghamaliyev U, Rippl M, Deissler L, Tausendfreund O, Nuebler D, Mueller K, Schmidmaier R, Drey M.   +9 more
europepmc   +1 more source

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

Molecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary, Jose Javier Bravo‐Cordero   +1 more
wiley   +1 more source

Developing a Virtual Reality Application for Social and Emotional Wellbeing and Cultural Determinants of Health Support With an Aboriginal Community of Sydney, New South Wales, Australia: Protocol for an Acceptability and Feasibility Study. [PDF]

JMIR Res Protoc
Garay J, Phillips S, Purdam J, Duczynski J, Azizi M, Dickson M, Carter M, Hespanhol L, Negin J, Mooney-Somers J.   +9 more
europepmc   +1 more source

Utility and clinical relevance of multiplex PCR panels for diagnosis of central nervous system infections. [PDF]

Indian J Med Res
Gürler M, Karaoğlu Ç, Yurtcu EE, Us E, Karahan ZC.   +4 more
europepmc   +1 more source

MITF maintains genome stability in nonmelanocyte lineages

Molecular Oncology, EarlyView.
MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created
Drifa H. Gudmundsdottir, Adrián López García de Lomana, Thejus B. Venkatesh, Kritika Kirty, Snaevar Sigurdsson, Linda Vidarsdottir, Ramile Dilshat, Erla Sveinbjornsdottir, Snaedis Ragnarsdottir, Daniel H Magnusson, Maria R. Bustos, Eirikur Steingrimsson, Thorkell Gudjonsson, Stefan Sigurdsson   +13 more
wiley   +1 more source